Investor Type | Firm |
Industries | Life Science |
Stages | Early |
Investing | China |
Investment Range | $3,500,000 - $181,000,000 |
FREES FUND is a venture capital firm that positions itself as an innovative player in the investment market, aiming to disrupt the traditional rules of venture capitalism. They are focused on the infusion of capital into early-stage startups, seeking to be the first-round institutional investor for ventures demonstrating high potential. With a strong inclination towards broad-sense Technology, Media, and Telecom (TMT), B2B sectors, and deep technology, FREES FUND is strategically targeting areas rich in transformative and scalable opportunities. Their investment approach is backed by an arsenal of cutting-edge technologies and an array of resources, with the purpose of nurturing startup growth into substantial societal value. The fund operates within the life sciences industry as well, which underscores their commitment to investing across a diverse spectrum of pioneering areas. FREES FUND's investment range underlines their flexibility and understanding of the varying capital needs of early-stage startups, with a minimum investment threshold of $3,500,000 and a maximum of $181,000,000. This broad range allows FREES FUND to tailor their financial support to the specific requirements of each startup, promoting a custom-fitted investment strategy that could propel startup enterprises to significant heights. By engaging with promising startups, FREES FUND strives to facilitate their evolution into great enterprises that can contribute meaningful advancements and value to society as a whole.